Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 4:57 AM ET

Healthcare Providers and Services

Company Overview of Profarma Distribuidora de Produtos Farmacêuticos S.A.

Company Overview

Profarma Distribuidora de Produtos Farmacêuticos S.A. is engaged in the distribution, wholesale, and retail of pharmaceutical and hospital products in Brazil. The company operates through Pharmaceutical Distribution, Hospital & Special Medications, and Retail segments. It provides medicines, personal care, beauty, and dermatological products; and toiletries, vaccines, prostheses, and hormones in the South, Southeast, Northeast, and Center-West regions of Brazil through 12 distribution centers. The company also operates approximately 140 stores in the state of Rio de Janeiro. In addition, it provides information technology, cargo and transportation planning and control, and sales promotion an...

Avenida das Américas

nº 500, Bloco 12

sala 106

Grupo 205 à 208, Barra da Tijuca

Rio de Janeiro, RJ 22640-100

Brazil

Founded in 1961

Phone:

55 21 4009 0276

Fax:

55 21 2494 7333

Key Executives for Profarma Distribuidora de Produtos Farmacêuticos S.A.

Profarma Distribuidora de Produtos Farmacêuticos S.A. does not have any Key Executives recorded.

Profarma Distribuidora de Produtos Farmacêuticos S.A. Key Developments

Profarma Distribuidora de Produtos Farmacêuticos S.A. Announces Consolidated and Parent Earnings Results for Fourth Quarter and Full Year Ended December 31, 2014

Profarma Distribuidora de Produtos Farmacêuticos S.A. announced consolidated and parent earnings results for fourth quarter and full year ended December 31, 2014. For the quarter, on consolidated basis, the company reported net operating revenue of BRL 872,688,000, operating loss prior to financial results of BRL 2,982,000, operating loss of BRL 24,611,000, net loss of BRL 20,156,000 or BRL 486 per batch of one thousand shares, cash used in operating activities of BRL 14,517,000, additions to fixed assets of BRL 8,481,000, additions to intangible assets of BRL 2,586,000 compared to the net operating revenue of BRL 862,248,000, operating profit prior to financial results of BRL 9,858,000, operating loss of BRL 5,868,000, net loss of BRL 4,603,000 or BRL 139 per batch of one thousand shares, cash used in operating activities of BRL 7,890,000, additions to fixed assets of BRL 3,734,000, additions to intangible assets of BRL 1,649,000 for the same quarter a year ago. For the year, on consolidated basis, the company reported net operating revenue of BRL 3,449,124,000, operating profit prior to financial results of BRL 4,176,000, operating loss of BRL 60,634,000, net loss of BRL 52,117,000 or BRL 1256 per batch of one thousand shares, cash used in operating activities of BRL 58,866,000, additions to fixed assets of BRL 22,025,000, additions to intangible assets of BRL 4,483,000 compared to the net operating revenue of BRL 3,470,310,000, operating profit prior to financial results of BRL 76,009,000, operating income of BRL 19,960,000, net income of BRL 20,353,000 or BRL 613 per batch of one thousand shares, cash used in operating activities of BRL 90,024,000, additions to fixed assets of BRL 6,648,000, additions to intangible assets of BRL 1,980,000 for the previous year. For the quarter, on parent basis, the company reported net operating revenue of BRL 837,904,000, operating loss prior to financial results of BRL 6,235,000, operating loss of BRL 24,646,000, net loss of BRL 20,156,000 or BRL -486 per batch of one thousand shares, cash used in operating activities of BRL 19,264,000, additions to fixed assets of BRL 4,943,000, additions to intangible assets of BRL 656,000 compared to the net operating revenue of BRL 750,888,000, operating profit prior to financial results of BRL 4,861,000, operating loss of BRL 6,838,000, net loss of BRL 4,603,000 or BRL -139 per batch of one thousand shares, cash used in operating activities of BRL 2,544,000, additions to fixed assets of BRL 1,247,000, additions to intangible assets of BRL 657,000 for the same quarter a year ago. For the year, on parent basis, the company reported net operating revenue of BRL 3,165,171,000, operating loss prior to financial results of BRL 15,034,000, operating loss of BRL 60,174,000, net loss of BRL 52,117,000 or BRL -1256 per batch of one thousand shares, cash used in operating activities of BRL 87,108,000, additions to fixed assets of BRL 8,279,000, additions to intangible assets of BRL 795,000 compared to the net operating revenue of BRL 3,085,103,000, operating profit prior to financial results of BRL 66,024,000, operating income of BRL 21,457,000, net income of BRL 20,353,000 or BRL 613 per batch of one thousand shares, cash used in operating activities of BRL 49,842,000, additions to fixed assets of BRL 3,855,000, additions to intangible assets of BRL 769,000 for the previous year.

Profarma Distribuidora de Produtos Farmacêuticos S.A. to Report Q4, 2014 Results on Mar 30, 2015

Profarma Distribuidora de Produtos Farmacêuticos S.A. announced that they will report Q4, 2014 results on Mar 30, 2015

Profarma Distribuidora de Produtos Farmacêuticos S.A., Q4 2014 Earnings Call, Mar 30, 2015

Profarma Distribuidora de Produtos Farmacêuticos S.A., Q4 2014 Earnings Call, Mar 30, 2015

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 20, 2014
Arp Med SA
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Profarma Distribuidora de Produtos Farmacêuticos S.A., please visit www.profarma.com.br. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.